News
13d
Stocktwits on MSNModerna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And OlderModerna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 ...
mNexspike is a lower-dose next-generation vaccine. Moderna says the new formula uses only one-fifth of the dose in its current COVID-19 shot.
mNEXSPIKE becomes Moderna’s third FDA-approved product. CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration ...
Hosted on MSN1mon
FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditionsThe primary efficacy was to demonstrate the vaccine efficacy against COVID-19 starting 14 days after mNEXSPIKE compared with Spikevax, Moderna's updated COVID-19 vaccine approved on Sept. 6, 2024.
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results